JP2019532668A5 - - Google Patents

Download PDF

Info

Publication number
JP2019532668A5
JP2019532668A5 JP2019531525A JP2019531525A JP2019532668A5 JP 2019532668 A5 JP2019532668 A5 JP 2019532668A5 JP 2019531525 A JP2019531525 A JP 2019531525A JP 2019531525 A JP2019531525 A JP 2019531525A JP 2019532668 A5 JP2019532668 A5 JP 2019532668A5
Authority
JP
Japan
Prior art keywords
seq
chimeric receptor
human
receptor ligand
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019531525A
Other languages
English (en)
Japanese (ja)
Other versions
JP6990244B2 (ja
JP2019532668A (ja
Filing date
Publication date
Priority claimed from CN201610795955.XA external-priority patent/CN107793481A/zh
Application filed filed Critical
Publication of JP2019532668A publication Critical patent/JP2019532668A/ja
Publication of JP2019532668A5 publication Critical patent/JP2019532668A5/ja
Application granted granted Critical
Publication of JP6990244B2 publication Critical patent/JP6990244B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019531525A 2016-08-31 2017-08-31 ヒトcd123を標的とするキメラ受容体リガンド及びその応用 Expired - Fee Related JP6990244B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610795955.X 2016-08-31
CN201610795955.XA CN107793481A (zh) 2016-08-31 2016-08-31 一种靶向人cd123的嵌合受体配体及其应用
PCT/CN2017/099941 WO2018041220A1 (zh) 2016-08-31 2017-08-31 一种靶向人cd123的嵌合受体配体及其应用

Publications (3)

Publication Number Publication Date
JP2019532668A JP2019532668A (ja) 2019-11-14
JP2019532668A5 true JP2019532668A5 (enExample) 2020-10-08
JP6990244B2 JP6990244B2 (ja) 2022-01-12

Family

ID=61300124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019531525A Expired - Fee Related JP6990244B2 (ja) 2016-08-31 2017-08-31 ヒトcd123を標的とするキメラ受容体リガンド及びその応用

Country Status (5)

Country Link
US (1) US11401317B2 (enExample)
EP (1) EP3508504A4 (enExample)
JP (1) JP6990244B2 (enExample)
CN (1) CN107793481A (enExample)
WO (1) WO2018041220A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157678A (zh) * 2018-02-12 2019-08-23 深圳宾德生物技术有限公司 一种靶向性t淋巴细胞及其制备方法和应用
KR20210031898A (ko) * 2018-07-13 2021-03-23 난징 레전드 바이오테크 씨오., 엘티디. 전염병을 치료하기 위한 공동수용체 시스템
CN109970869A (zh) * 2019-04-12 2019-07-05 南京卡提医学科技有限公司 一种靶向人trail死亡受体的嵌合受体配体及其应用
CN110904048A (zh) * 2019-12-04 2020-03-24 合肥中科干细胞再生医学有限公司 一种car-cd123t2嵌合抗原受体t细胞及其应用
WO2023000036A1 (en) * 2021-07-22 2023-01-26 The Westmead Institute for Medical Research Chimeric antigen receptor useful in treating cancer
JP2024528086A (ja) * 2021-07-29 2024-07-26 ブイオーアール バイオファーマ インコーポレーテッド がん治療用キメラ抗原受容体
CN117126856A (zh) * 2022-05-20 2023-11-28 上海雅科生物科技有限公司 以bcma胞外结构域为标记的基因、多肽、重组表达载体、基因工程化细胞及其应用
CN115819622A (zh) * 2022-09-26 2023-03-21 湖南省人民医院(湖南师范大学附属第一医院) 针对b系白血病或淋巴瘤的双靶点car结构及药物组合物
CN116179495B (zh) * 2022-11-28 2025-06-06 上海恩凯细胞技术有限公司 转基因免疫细胞及其应用
CN117659196B (zh) * 2023-12-12 2024-08-23 成都优赛诺生物科技有限公司 一种靶向cd7的单域抗体、嵌合抗原受体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763242B2 (en) * 2006-09-07 2010-07-27 Scott and White Memorial Hospital Methods for treating myelodysplastic syndrome with a human interleukin-3-diphtheria toxin conjugate
US8822647B2 (en) * 2008-08-26 2014-09-02 City Of Hope Method and compositions using a chimeric antigen receptor for enhanced anti-tumor effector functioning of T cells
ES2714523T3 (es) * 2012-09-04 2019-05-28 Cellectis Receptor quimérico de antígenos multicatenario y usos del mismo
US9657105B2 (en) * 2013-03-15 2017-05-23 City Of Hope CD123-specific chimeric antigen receptor redirected T cells and methods of their use
US9944709B2 (en) * 2014-03-19 2018-04-17 Cellectis CD123 specific chimeric antigen receptors for cancer immunotherapy
JP2017519502A (ja) * 2014-06-17 2017-07-20 セレクティスCellectis Cd123特異的多重鎖キメラ抗原受容体
SG11201700770PA (en) * 2014-08-19 2017-03-30 Novartis Ag Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment

Similar Documents

Publication Publication Date Title
HRP20231542T1 (hr) Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe
JP2019527557A5 (enExample)
JP2021094037A5 (enExample)
JP2020517295A5 (enExample)
JP2017529851A5 (enExample)
IL277079B1 (en) Cartyrin compositions and methods for use
JP2021106605A5 (enExample)
JP2016514691A5 (enExample)
JP2016534717A5 (enExample)
FI3909972T3 (fi) Pd1-cd28-fuusioproteiineja ja niiden käyttö lääkkeessä
JP2020512005A5 (enExample)
JP2018516092A5 (enExample)
JP2024502632A5 (enExample)
JP2018525033A5 (enExample)
FI3710067T3 (fi) Polypeptidejä sisältävä d-domeeni ja niiden käyttötarkoitukset
HRP20241057T1 (hr) Kimerni antigenski receptori na osnovu jedno-domenskih antitijela i načini njihove uporabe
JP2017518071A5 (enExample)
JP2021500881A5 (enExample)
HRP20210498T1 (hr) De novo vezujuća domena koja sadrži polipeptide i njihova upotreba
JP2019500894A5 (enExample)
RU2015109631A (ru) Способ и композиции для клеточной иммунотерапии
RU2017123548A (ru) Химерные антигенные рецепторы, нацеленные на антиген созревания в-клеток, и их применение
JP2020513754A5 (enExample)
JP2023534808A5 (enExample)
JP2017522862A5 (enExample)